Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2009-04-15
2013-01-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Magnetic resonance imaging (MRI) uses a strong magnetic field and radio waves to take pictures of the brain. Some MRI studies suggest that this technique reveals brain differences in patients with a nervous system illness when compared to adults without a nervous system illness.
Objectives:
* To study functional changes in the brain that may be observed in people without any nervous system illness.
* To learn more about which areas of the brain are necessary to perform certain tasks, especially learning simple motor sequences and processing rewards.
Eligibility:
* Healthy volunteers between the ages of 18 and 50 who are right-handed and are native English speakers, and who have no medical conditions that would prevent them from undergoing magnetic imaging.
* Volunteers must not have a history of neurological or psychiatric illnesses.
* Female volunteers must not be pregnant.
Design:
* Volunteers will be asked to undergo different types of magnetic imaging, including functional magnetic resonance imaging (fMRI), magnetic resonance spectroscopy (MRS), and/or transcranial magnetic stimulation (TMS), while participating in either a slot machine simulation or a key sequence learning task.
* Volunteers will participate in one of four possible experiments:
* Experiment 1: MRS/TMS and slot machine (3 visits, 3.5 hours in total).
* Experiment 2: MRS/TMS and key sequence (3 visits, 3.5 hours in total).
* Experiment 3: fMRI and slot machine (2 visits, 3 hours in total).
* Experiment 4: fMRI and key sequence (1 visit, 2 hours in total).
* Experiment types:
* Slot machine: A computer game like a slot machine, where the user presses a button to start the game and watches as the three barrels of the machine spin into place.
* Key sequence: Pressing a series of buttons in response to visual cues.
* Volunteers will also be asked to give a small blood sample for genetic testing.
* Volunteers will be paid a small amount of money (approximately $50 $80) during the experiments in compensation for their participation in the study.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Population: The population that we will study will be healthy volunteers between the ages of 18-50, without any significant medical history or contraindication to functional magnetic resonance imaging (fMRI).
Design: All experiments will employ within- or between-subjects fMRI and magnetic resonance spectroscopy (MRS) to measure changes in activations of different cortical areas in response to motor learning and reward.
Outcome Measures: The outcome measures will be (a) graded changes in blood oxygen level-dependent (BOLD) in response to motor learning and reward and (b) variations in GABA concentration in response to motor learning and reward, and c) variations in response time in the behavioral performance of a learning task.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right handed.
Exclusion Criteria
* Habitual consumption of more than two drinks a day, marijuana more than once a week or any other illicit drug use within the last three months
* Use of medication affecting the DA system, such as phenothiazine antihistamines (promethazine), antiemetics or decongestants within the last month
* Significant abnormality on neurological examination
* Metal in the cranial cavity or eye, pacemaker, implanted pumps or stimulators
* Subjects who participate in any one experiment in this protocol may not participate in another experiment in this protocol.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
National Institutes of Health Clinical Center (CC)
NIH
Center for Neuroscience and Regenerative Medicine (CNRM)
FED
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric M Wassermann, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arancio O, Chao MV. Neurotrophins, synaptic plasticity and dementia. Curr Opin Neurobiol. 2007 Jun;17(3):325-30. doi: 10.1016/j.conb.2007.03.013. Epub 2007 Apr 6.
Ashe J, Lungu OV, Basford AT, Lu X. Cortical control of motor sequences. Curr Opin Neurobiol. 2006 Apr;16(2):213-21. doi: 10.1016/j.conb.2006.03.008. Epub 2006 Mar 24.
Avanzi M, Uber E, Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurol Sci. 2004 Jun;25(2):98-101. doi: 10.1007/s10072-004-0238-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-N-0124
Identifier Type: -
Identifier Source: secondary_id
090124
Identifier Type: -
Identifier Source: org_study_id